Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 9.978\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CCCc1cc(=O)[nH]c(SCC(=O)NC(=O)NC2CCCC2)n1
b CCOC(=O)C(=O)Nc1nnc(COc2ccc(Cl)cc2)s1
c CCOC(=O)CNC(=O)c1cnc(Nc2ccccc2OC)c2ccccc12
Answer: a. CCCc1cc(=O)[nH]c(SCC(=O)NC(=O)NC2CCCC2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCc1cc(=O)[nH]c(SCC(=O)NC(=O)NC2CCCC2)n1
CCCc1cc(=O)[nH]c(SCC(=O)NC(=O)NC2CCCC2)n1
N-(cyclopentylcarbamoyl)-2-[(6-oxo-4-propyl-1H-pyrimidin-2-yl)sulfanyl]acetamide